Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
None CAD 0.00(0%)
Last update at 2024-07-16T16:03:00.567968Z
Market Cap
25.93M
P/E
1.01

Momentum Score

…

Xybion Digital Inc., a software-as-a-service company, provides software solutions for life sciences and health systems companies in the United States and internationally. Its software solutions include Pristima XD, an integrated digital laboratory execution system; Labwise XD, a laboratory operations software to manage GMP and non-GMP-compliant process flows; and digital pathology software solutions. The company also provides COVID-19 test management application; Savante, a data warehouse, analytics, and SEND management system; QMS suite, an end-to-end unified cloud platforms for research and development, laboratory information management systems, and workplace health and safety; Compliance Risk Predictor to predict compliance risks, mitigate, and eliminate; and Compliance Builder, a real-time compliance monitoring software. In addition, it offers Emidence XD, a total workforce health and safety solution; and ECM XD, a cloud-based digital platform for managing enterprise content. Further, the company provides project management, computer system validation, and software development and testing services. It serves clients in life sciences, workplace health, safety and worker's compensation, transportation, energy, financial services, enterprise solutions, healthcare and insurance, and government industries. The company is headquartered in Princeton, New Jersey. Xybion Digital Inc. is a subsidiary of Banerjee Group LLC.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.32
Low
2.24
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
0.90
Dividend Yield
-
Revenue TTM
16.58M
Revenue Per Share
0.32
Gross Profit TTM
10.38M
Debt / Equity
-
ROE
-54.07%
Net Debt
-
ROCE
-3.03%
Diluted EPS TTM
0.49

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly yearly
Date 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Income before tax -0.32M -1.75M -0.56M 2.79M 1.80M
Net income -0.31M -1.33M -0.98M 2.28M 1.39M
Selling general administrative 8.46M 8.85M 6.98M 5.59M 5.99M
Gross profit 11.12M 10.38M 11.15M 9.41M 9.52M
Reconciled depreciation 0.46M 0.46M 0.46M 0.46M 0.47M
Ebit - -1.67M 1.80M 1.79M 1.86M
Ebitda - - -0.08M 3.26M 2.28M
Operating income -0.25M -1.67M 1.98M 1.89M 1.86M
Other operating expenses - 0.64M 0.45M 0.29M 0.48M
Interest expense - 0.01M 0.02M 0.01M 0.02M
Tax provision -0.01M -0.42M 0.42M 0.51M 0.41M
Net interest income -0.03M -0.05M -0.02M -0.01M -0.02M
Income tax expense - -0.42M 0.42M 0.51M 0.41M
Total revenue 16.85M 16.44M 16.77M 14.32M 15.14M
Total operating expenses 17.11M 18.11M 14.79M 12.43M 13.28M
Cost of revenue 5.74M 6.05M 5.62M 4.91M 5.62M
Total other income expense net -0.03M -0.02M -2.52M 0.92M -0.05M
Net income from continuing ops -0.31M -1.33M -0.98M 2.28M 1.39M
Net income applicable to common shares - -1.33M -0.98M 2.28M 1.39M
Breakdown 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Type yearly yearly yearly yearly yearly
Date 2022-09-30 2021-09-30 2020-09-30 2019-09-30 2018-09-30
Total assets 16.56M 17.48M 16.14M 12.89M 11.65M
Other current assets 0.12M - 0.03M - -
Total liab 8.71M 8.15M 8.13M 6.48M 6.04M
Total stockholder equity 7.85M 9.32M 8.02M 6.41M 5.61M
Deferred long term liab 0.17M - 0.01M - -
Other current liab 6.99M 6.79M 6.30M 5.23M 4.60M
Common stock 5.56M 5.55M 2.48M 0.15M 0.15M
Capital stock 5.56M 5.55M 0.15M 0.15M 0.15M
Retained earnings 2.20M 3.53M 5.26M 3.73M 2.95M
Good will 2.30M 2.31M 2.31M 2.29M 2.30M
Other assets 0.85M 0.23M 0.50M 0.58M 0.66M
Cash 5.29M 8.15M 6.46M 4.12M 3.41M
Total current liabilities 8.16M 7.71M 7.46M 6.29M 5.70M
Other stockholder equity -0.29M -0.10M -0.01M -0.06M 0.02M
Property plant equipment 1.09M 0.96M 1.36M 0.77M 0.78M
Total current assets 12.32M 13.97M 11.97M 9.24M 7.90M
Net tangible assets 5.55M 7.01M 5.70M 4.11M 3.31M
Net receivables 6.40M 5.13M 5.12M 4.82M 4.14M
Accounts payable 0.41M 0.34M 0.41M 0.33M 0.45M
Non current assets total 4.24M 3.50M 4.17M 3.65M 3.74M
Capital lease obligations 0.90M 0.67M 1.02M 0.51M 0.62M
Breakdown 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Type yearly yearly yearly yearly yearly
Date 2023-09-30 2022-09-30 2021-09-30 2020-09-30 2019-09-30
Investments -0.02M -0.02M 0.71M -0.24M -0.26M
Change to liabilities - 0.62M 0.41M 1.05M 0.64M
Total cashflows from investing activities - -0.02M 0.71M -0.24M -0.26M
Net borrowings - -0.34M -0.35M 0.75M -0.31M
Total cash from financing activities -0.37M -0.55M -0.07M 0.00M -0.91M
Change to operating activities - 0.03M -0.38M -0.07M -0.00M
Net income 1.25M -1.33M -0.37M 2.28M 1.39M
Change in cash 1.41M -2.86M 1.69M 2.34M 0.72M
Begin period cash flow 5.42M 8.15M 6.46M 4.12M 3.41M
End period cash flow 6.93M 5.29M 8.15M 6.46M 4.12M
Total cash from operating activities 1.89M -2.12M 1.15M 2.54M 1.96M
Issuance of capital stock 0.01M 0.00M 1.78M 0.00M -
Depreciation 0.49M 0.46M 0.46M 0.46M 0.47M
Dividends paid 0.00M 0.00M 0.75M 0.75M 0.60M
Change to account receivables -0.94M -1.23M 0.07M -0.35M -0.62M
Other cashflows from financing activities - -0.21M -0.75M -0.75M -0.75M
Change to netincome - -0.42M 1.60M -0.91M 0.17M
Capital expenditures 0.02M 0.02M 0.07M 0.24M 0.26M
Change in working capital -0.31M -0.87M 0.06M 0.72M -0.06M
Stock based compensation 0.04M 0.03M 0.03M 0.03M 0.09M
Other non cash items 0.07M 0.04M 1.30M - -
Free cash flow 1.88M -2.14M 1.08M 2.31M 1.70M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
NURS
Hydreight Technologies Inc
-0.04
1.32%
2.98 406.00 25.91 7.85 20.38 7.45 109.02
ADK
Diagnos Inc
-0.01
1.41%
0.35 - 10.00 411.24 18.74 389.06 -6.16
NXG
NexgenRX Inc.
-
-%
0.66 39.00 32.68 1.55 4.64 1.39 7.84
PTEC
Principal Technologies Inc
-
-%
0.32 - - 62.75 355.42 72.08 -0.81

Profile*

Xybion Digital Inc.

Xybion Digital Inc., a software-as-a-service company, provides software solutions for life sciences and health systems companies in the United States and internationally. Its software solutions include Pristima XD, an integrated digital laboratory execution system; Labwise XD, a laboratory operations software to manage GMP and non-GMP-compliant process flows; and digital pathology software solutions. The company also provides COVID-19 test management application; Savante, a data warehouse, analytics, and SEND management system; QMS suite, an end-to-end unified cloud platforms for research and development, laboratory information management systems, and workplace health and safety; Compliance Risk Predictor to predict compliance risks, mitigate, and eliminate; and Compliance Builder, a real-time compliance monitoring software. In addition, it offers Emidence XD, a total workforce health and safety solution; and ECM XD, a cloud-based digital platform for managing enterprise content. Further, the company provides project management, computer system validation, and software development and testing services. It serves clients in life sciences, workplace health, safety and worker's compensation, transportation, energy, financial services, enterprise solutions, healthcare and insurance, and government industries. The company is headquartered in Princeton, New Jersey. Xybion Digital Inc. is a subsidiary of Banerjee Group LLC.

105 College Street East, Princeton, NJ, United States, 08540

609 512 5790

Name Title Year Born
Dr. Pradip K. Banerjee M.B.A., Ph.D. Founder, CEO & Chairman NA
Mr. Kamal Biswas Pres & COO NA
Mr. Steven L. Porfano CFO, Corp. Sec. & Exec. VP NA
Mr. Mustafa Abdallah Exec. Director of Quality & Compliance Services NA
Mr. Bob Friedman Chief Solution Architect NA
Ms. Priya Rajesh Head of Sales - APAC & EMEA NA
Mr. Shawn Rabenstein Head of IT NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…